The role and limitation of living donor liver transplantation for hepatocellular carcinoma
Open Access
- 26 February 2004
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Liver Transplantation
- Vol. 10 (3), 440-447
- https://doi.org/10.1002/lt.20097
Abstract
Liver transplantation for hepatocellular carcinoma (HCC) is restricted by the scarcity of cadaver grafts. Living donor liver transplantation (LDLT) may potentially increase the applicability but its role and limitation are not clear. We studied the outcome of a cohort of 51 patients with unresectable HCC who were accepted on list for both options of deceased donor liver transplantation (DDLT) and LDLT. Twenty-five of 51 (49%) patients had voluntary living donors (group 1) and 26 did not (group 2). Patients in group 1 were younger, and more often had a MELD score more than 20 or blood group other than O. Twenty-one patients of group 1 underwent LDLT after a median waiting time of 24 days (range, 2–126 days), but 4 did not because the donors were not suitable (HBsAg-positive, 2; ABO-incompatible, 1; liver dysfunction, 1). Of the 30 patients who remained on list, only 6 underwent DDLT after a median waiting time of 344 days (range, 22–1359 days, P < .005). Nineteen died before transplantation and 2 were alive but taken off the list because of disease progression (drop-out rate, 70%). One patient was alive on list and 2 had undergone transplantation outside Hong Kong. The 1-, 2-, 3-, and 4-year intention-to-treat survival rates were 88%, 76%, 66%, and 66%, respectively, for group 1 and 72%, 46%, 38%, and 31%, respectively, for group 2 (relative risk of death for group 1, 0.35; 95% CI, 0.14 to 0.90; P = .029). In conclusion, although complicated factors such as donor voluntarism and selection criteria limit the role of LDLT for HCC, LDLT allows more patients to undergo early transplantation and results in a better outcome. (Liver Transpl 2004;10:440–447.)Keywords
This publication has 21 references indexed in Scilit:
- Liver transplantation for hepatocellular carcinoma: Analysis of survival according to the intention-to-treat principle and dropout from the waiting listLiver Transplantation, 2002
- Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survivalHepatology, 2001
- Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspectiveHepatology, 2001
- Single-center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobeLiver Transplantation, 2000
- RIGHT LOBE GRAFT IN LIVING DONOR LIVER TRANSPLANTATION 1,2Transplantation, 2000
- Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantationHepatology, 1999
- Liver transplantation for small hepatocellular carcinoma: The tumor-node-metastasis classification does not have prognostic powerHepatology, 1998
- Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: A comparative studyHepatology, 1997
- Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with CirrhosisNew England Journal of Medicine, 1996
- Donor selection limits use of living-related liver transplantationHepatology, 1995